Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 15, 2017
- Accepted for publication May 11, 2017
- Published online July 3, 2017.
Article Versions
- previous version (May 18, 2017 - 07:57).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Adriaan A. Lammertsma
- Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
- For correspondence or reprints contact: Adriaan A. Lammertsma, Department of Radiology and Nuclear Medicine, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: aa.lammertsma{at}vumc.nl
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Fully Automated, Semantic Segmentation of Whole-Body 18F-FDG PET/CT Images Based on Data-Centric Artificial Intelligence
- caliPER: A software for blood-free parametric Patlak mapping using PET/MRI input function
- Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
- 11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy
- Conditional Generative Adversarial Networks Aided Motion Correction of Dynamic 18F-FDG PET Brain Studies
- Measurement of PET Quantitative Bias In Vivo
- Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
- Exploiting the Full Potential of {beta}-Amyloid and Tau PET Imaging for Drug Efficacy Testing
- PET Imaging of Pancreatic Dopamine D2 and D3 Receptor Density with 11C-(+)-PHNO in Type 1 Diabetes
- Promise of Fully Integrated PET/MRI: Noninvasive Clinical Quantification of Cerebral Glucose Metabolism
- 89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
- Amyloid Load: A More Sensitive Biomarker for Amyloid Imaging
- Assessing Amyloid Pathology in Cognitively Normal Subjects Using 18F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
- Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
- Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol
- Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care